Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

332
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
332
Gastroesophageal Reflux Disease I: Meaning and Pathophysiology01:29

Gastroesophageal Reflux Disease I: Meaning and Pathophysiology

614
Gastroesophageal Reflux Disease (GERD) involves the recurrent backflow of the stomach or duodenal contents into the esophagus, leading to troublesome symptoms and potential esophageal mucosal damage. Although GERD is often referred to as a disease, it is more accurately described as a syndrome, as it encompasses a range of symptoms and complications rather than a singular pathological entity, impacting a large number of individuals as the most prevalent upper gastrointestinal problem. Roughly...
614
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

709
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
709
Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

348
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
348
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

256
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
256
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

1.1K
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Response and Improvement of the Quality of Life, Fatigue, Mood, and Sleep Disturbances During Vedolizumab Induction Therapy in Polish Patients With Moderate-to-Severe Ulcerative Colitis or Crohn's Disease.

Canadian journal of gastroenterology & hepatology·2026
Same author

Liver function disorders in pregnancy: physiology or pathology?

Przeglad gastroenterologiczny·2026
Same author

Diagnostic and Prognostic Potential of CXCL9 and CXCL10 Chemokines in Alcohol-Associated Liver Disease.

International journal of molecular sciences·2025
Same author

Transarterial chemoembolization with bleomycin and lipiodol: a novel treatment for giant hepatic haemangiomas.

Polish journal of radiology·2025
Same author

Diagnostic and therapeutic guidelines for pancreatic cystic tumors: recommendations of Polish Pancreatic Club experts.

Przeglad gastroenterologiczny·2025
Same author

Is There a Diagnostic Miracle on the Horizon? Emerging Biomarkers in MASLD.

Journal of clinical medicine·2025
Same journal

Women in gastroenterology: what is the current situation? Results of a Polish National Survey.

Przeglad gastroenterologiczny·2026
Same journal

Study of serum long non-coding RNA interferon gamma antisense-1 as a biomarker of activity in Crohn's disease.

Przeglad gastroenterologiczny·2026
Same journal

RESCUE-CD - Real-world effectiveness of risankizumab in moderate-to-severe Crohn's disease: a case series involving the most refractory and challenging patients.

Przeglad gastroenterologiczny·2026
Same journal

Diverticular disease increases the risk of acute myocardial infarction.

Przeglad gastroenterologiczny·2026
Same journal

Dynamic platelet count value as a clinical indicator of postoperative pancreatic fistula after pancreatic resections.

Przeglad gastroenterologiczny·2026
Same journal

Chronic pancreatitis associated with genetic mutation and drug-resistant epilepsy.

Przeglad gastroenterologiczny·2026
See all related articles

Related Experiment Video

Updated: Oct 18, 2025

Author Spotlight: A Focus on Standardized Salivary Gland Ultrasound Protocol in Connective Tissue Disease Research
07:25

Author Spotlight: A Focus on Standardized Salivary Gland Ultrasound Protocol in Connective Tissue Disease Research

Published on: October 13, 2023

3.5K

Gullo's syndrome - what do we know?

Anna Rycyk1, Paulina Furtak2, Agnieszka Mądro1

  • 1Department of Gastroenterology with Endoscopy Unit, Medical University, Lublin, Poland.

Przeglad Gastroenterologiczny
|September 29, 2021
PubMed
Summary
This summary is machine-generated.

Gullo's syndrome, or benign pancreatic hyperenzymemia, involves elevated pancreatic enzymes without pancreatic disease. Accurate diagnosis is crucial to avoid unnecessary tests for this condition.

Keywords:
Gullo's syndromebenign pancreatic hyperenzymemia

More Related Videos

Author Spotlight: Studying Clinical Characters and Epilepsy Outcomes After Frontal Disconnection in Patients with MOGHE
06:04

Author Spotlight: Studying Clinical Characters and Epilepsy Outcomes After Frontal Disconnection in Patients with MOGHE

Published on: August 16, 2024

1.1K
Determining Bile Duct Density in the Mouse Liver
07:35

Determining Bile Duct Density in the Mouse Liver

Published on: April 30, 2019

7.1K

Related Experiment Videos

Last Updated: Oct 18, 2025

Author Spotlight: A Focus on Standardized Salivary Gland Ultrasound Protocol in Connective Tissue Disease Research
07:25

Author Spotlight: A Focus on Standardized Salivary Gland Ultrasound Protocol in Connective Tissue Disease Research

Published on: October 13, 2023

3.5K
Author Spotlight: Studying Clinical Characters and Epilepsy Outcomes After Frontal Disconnection in Patients with MOGHE
06:04

Author Spotlight: Studying Clinical Characters and Epilepsy Outcomes After Frontal Disconnection in Patients with MOGHE

Published on: August 16, 2024

1.1K
Determining Bile Duct Density in the Mouse Liver
07:35

Determining Bile Duct Density in the Mouse Liver

Published on: April 30, 2019

7.1K

Area of Science:

  • Gastroenterology
  • Biochemistry

Background:

  • Benign pancreatic hyperenzymemia, known as Gullo's syndrome, is defined by elevated serum lipase and amylase.
  • This condition occurs in the absence of any underlying pancreatic pathology.

Purpose of the Study:

  • To highlight the increasing recognition of Gullo's syndrome in medical literature.
  • To emphasize the importance of accurate diagnosis and awareness of differential diagnoses.

Main Methods:

  • Diagnosis of exclusion based on laboratory findings.
  • Clinical evaluation to rule out other causes of hyperenzymemia.

Main Results:

  • Characterized by a >3-fold increase in serum pancreatic enzymes.
  • Requires differentiation from other conditions causing enzyme elevation.

Conclusions:

  • Gullo's syndrome is a diagnosis of exclusion requiring careful clinical assessment.
  • Awareness of this syndrome and its diagnostic criteria is essential for clinicians to prevent unnecessary investigations.